Clinical trials
Cognitive Dysfunction trials in Hong Kong with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 10 |
| Unknown status | 7 |
| Not yet recruiting | 4 |
| Enrolling by invitation | 4 |
| Suspended | 1 |
| Terminated | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Hong Kong Polytechnic University | 17 |
| The University of Hong Kong | 17 |
| Chinese University of Hong Kong | 10 |
| City University of Hong Kong | 2 |
| Hong Kong Metropolitan University | 2 |
| CHAN SAU MAN, SANDRA | 1 |
| Education University of Hong Kong | 1 |
| Hong Kong Baptist University | 1 |
| Kit Wa Chan | 1 |
| Kowloon Hospital, Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 55 |
| Dementia | 7 |
| Parasomnias | 4 |
| Alzheimer Disease | 3 |
| Schizophrenia | 3 |
| Central Nervous System Diseases | 2 |
| Frailty | 2 |
| Autistic Disorder | 1 |
| Breast Neoplasms | 1 |
| Choroid Diseases | 1 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.